Header Logo

Anupama Munshi

Concepts (267)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
ELAV-Like Protein 1
8
2021
30
1.970
Why?
Lung Neoplasms
21
2021
340
1.930
Why?
RNA, Small Interfering
13
2021
195
1.610
Why?
Antineoplastic Agents
16
2023
658
1.530
Why?
Drug Delivery Systems
15
2023
216
1.520
Why?
Neoplasms
13
2025
766
1.350
Why?
Nanoparticles
13
2020
276
1.200
Why?
Radiation-Sensitizing Agents
5
2017
32
1.200
Why?
Radiation Tolerance
8
2020
28
1.180
Why?
DNA Damage
7
2022
149
1.170
Why?
Triple Negative Breast Neoplasms
2
2017
36
1.060
Why?
Cell Line, Tumor
25
2022
1268
1.030
Why?
Exosomes
7
2024
92
0.990
Why?
Interleukins
8
2025
111
0.840
Why?
RNA-Binding Proteins
2
2022
83
0.830
Why?
Apoptosis
13
2021
740
0.780
Why?
Tumor Microenvironment
2
2021
156
0.690
Why?
Phenylurea Compounds
1
2020
16
0.690
Why?
Pyridines
2
2020
102
0.650
Why?
Carcinoma, Non-Small-Cell Lung
8
2017
103
0.640
Why?
Protein Kinase Inhibitors
1
2020
143
0.630
Why?
Breast Neoplasms
1
2022
447
0.560
Why?
Enzyme Inhibitors
5
2006
247
0.550
Why?
Humans
47
2025
27116
0.550
Why?
Polycomb Repressive Complex 1
1
2017
34
0.540
Why?
Histone Deacetylase Inhibitors
2
2006
26
0.510
Why?
DNA Repair
6
2008
81
0.500
Why?
Cell Proliferation
8
2022
774
0.490
Why?
Adenocarcinoma
1
2016
288
0.440
Why?
Cisplatin
4
2020
175
0.440
Why?
Drug Carriers
4
2023
110
0.420
Why?
Cell Movement
7
2022
353
0.390
Why?
Melanoma
4
2006
128
0.380
Why?
Nanomedicine
4
2021
62
0.360
Why?
Dendrimers
3
2020
15
0.350
Why?
Gene Expression Regulation, Neoplastic
6
2021
445
0.350
Why?
Hydroxamic Acids
3
2006
18
0.350
Why?
Polymers
3
2017
114
0.340
Why?
Biomarkers, Tumor
3
2024
377
0.340
Why?
Histones
2
2006
90
0.320
Why?
Cell Survival
6
2017
395
0.310
Why?
Folate Receptor 1
2
2017
10
0.280
Why?
RNAi Therapeutics
2
2016
13
0.270
Why?
Doxorubicin
2
2016
74
0.260
Why?
Genetic Therapy
3
2017
116
0.240
Why?
Endocytosis
2
2022
81
0.230
Why?
Genes, Tumor Suppressor
4
2021
37
0.220
Why?
Ovarian Neoplasms
2
2024
566
0.220
Why?
Radiation, Ionizing
3
2016
25
0.220
Why?
NF-kappa B
1
2004
187
0.220
Why?
Gene Expression Regulation
2
2022
626
0.210
Why?
Immunotherapy
2
2021
141
0.200
Why?
Molecular Targeted Therapy
3
2021
127
0.200
Why?
Adenoviridae
5
2007
65
0.200
Why?
ErbB Receptors
1
2022
95
0.200
Why?
RNA
1
2022
104
0.190
Why?
Antigens, CD
1
2022
134
0.190
Why?
Female
6
2024
14633
0.190
Why?
Combined Modality Therapy
7
2020
290
0.190
Why?
Lung Diseases
1
2021
42
0.180
Why?
Immunity
1
2021
26
0.180
Why?
Medical Oncology
1
2021
86
0.170
Why?
Tumor Cells, Cultured
6
2017
310
0.170
Why?
Blotting, Western
5
2015
506
0.170
Why?
Extracellular Vesicles
1
2020
36
0.160
Why?
Liposomes
2
2017
142
0.160
Why?
Diabetes Mellitus
1
2021
213
0.160
Why?
Comet Assay
2
2016
5
0.160
Why?
Membrane Proteins
1
2022
467
0.150
Why?
Proto-Oncogene Proteins c-akt
2
2016
153
0.150
Why?
Cell Cycle
3
2015
155
0.150
Why?
Chitosan
2
2017
31
0.150
Why?
Reactive Oxygen Species
2
2016
280
0.150
Why?
Gene Transfer Techniques
2
2017
66
0.150
Why?
Integrin alphaVbeta3
1
2017
10
0.150
Why?
G1 Phase Cell Cycle Checkpoints
1
2017
5
0.150
Why?
Theranostic Nanomedicine
1
2018
22
0.150
Why?
Caspases
1
2017
43
0.140
Why?
Drug Discovery
1
2017
32
0.140
Why?
Mitochondria
2
2017
342
0.140
Why?
Antineoplastic Agents, Phytogenic
1
2017
52
0.140
Why?
Animals
11
2025
10078
0.140
Why?
Drug Resistance, Multiple
1
2017
20
0.140
Why?
Oncogenes
1
2017
34
0.140
Why?
MicroRNAs
2
2021
281
0.140
Why?
HMGA1a Protein
1
2016
4
0.140
Why?
Thioredoxin-Disulfide Reductase
1
2016
14
0.140
Why?
Fluorescent Antibody Technique
4
2015
111
0.140
Why?
Paclitaxel
1
2017
184
0.130
Why?
Autophagy
1
2017
72
0.130
Why?
Ku Autoantigen
2
2006
12
0.130
Why?
Antigens, Nuclear
2
2006
22
0.130
Why?
Acetylation
2
2006
36
0.130
Why?
Lipids
1
2017
198
0.130
Why?
Cell Line
4
2005
681
0.130
Why?
Nanotubes
1
2015
15
0.130
Why?
Heterocyclic Compounds
1
2015
15
0.130
Why?
Receptors, CXCR4
1
2015
27
0.120
Why?
Metal Nanoparticles
1
2016
128
0.120
Why?
Protein Processing, Post-Translational
1
2015
101
0.120
Why?
Gold
1
2015
129
0.120
Why?
Technology, Pharmaceutical
1
2014
9
0.110
Why?
Lactic Acid
1
2014
89
0.110
Why?
Diagnostic Imaging
1
2014
64
0.110
Why?
Fibroblasts
3
2016
153
0.100
Why?
Proto-Oncogene Proteins c-met
1
2012
12
0.100
Why?
DNA-Binding Proteins
2
2006
481
0.100
Why?
Oxidative Stress
1
2016
635
0.100
Why?
Transfection
4
2007
313
0.100
Why?
Neoplasm Invasiveness
3
2017
180
0.100
Why?
Down-Regulation
2
2015
198
0.100
Why?
Clinical Trials as Topic
3
2020
205
0.090
Why?
Dose-Response Relationship, Radiation
3
2004
36
0.090
Why?
Proteasome Endopeptidase Complex
2
2014
80
0.080
Why?
Tumor Suppressor Protein p53
3
2006
99
0.080
Why?
Dose-Response Relationship, Drug
3
2005
589
0.080
Why?
Enzyme Activation
3
2016
264
0.080
Why?
Folic Acid
2
2020
32
0.070
Why?
Mesoderm
1
2007
12
0.070
Why?
Quinazolines
1
2008
31
0.070
Why?
Mammary Neoplasms, Animal
1
2007
21
0.070
Why?
Signal Transduction
3
2021
1379
0.070
Why?
Gene Silencing
2
2017
64
0.070
Why?
Stem Cells
1
2007
113
0.070
Why?
Cell Nucleus
2
2004
135
0.070
Why?
Genes, p53
1
2006
14
0.070
Why?
Neovascularization, Pathologic
2
2006
144
0.070
Why?
Receptors, Transferrin
2
2017
17
0.070
Why?
Acid Anhydride Hydrolases
1
2006
1
0.070
Why?
DNA Repair Enzymes
1
2006
9
0.070
Why?
Caspase 9
2
2016
16
0.070
Why?
Microtubule-Associated Proteins
1
2006
49
0.070
Why?
Drug Liberation
2
2016
24
0.070
Why?
Immunoglobulin Variable Region
1
2006
7
0.070
Why?
Drug Resistance, Neoplasm
2
2020
149
0.070
Why?
Doxycycline
2
2016
19
0.070
Why?
Antibodies, Neoplasm
1
2006
7
0.070
Why?
Serine Endopeptidases
1
2006
18
0.060
Why?
Cell Death
2
2016
111
0.060
Why?
Neoplasm Proteins
1
2006
123
0.060
Why?
Butyrates
1
2005
13
0.060
Why?
Histone Deacetylases
1
2005
22
0.060
Why?
Kinetics
2
2016
538
0.060
Why?
Triglycerides
1
2005
120
0.060
Why?
Carcinoma, Squamous Cell
1
2006
155
0.060
Why?
Leupeptins
1
2004
7
0.060
Why?
Cysteine Proteinase Inhibitors
1
2004
13
0.060
Why?
Dimethyl Sulfoxide
1
2004
11
0.060
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
2004
31
0.060
Why?
Proteasome Inhibitors
1
2004
25
0.060
Why?
Benzamides
1
2004
33
0.060
Why?
MAP Kinase Signaling System
1
2004
93
0.060
Why?
Mitogen-Activated Protein Kinases
1
2003
83
0.050
Why?
Protein Biosynthesis
1
2003
109
0.050
Why?
Phosphorylation
2
2015
567
0.050
Why?
Integrins
1
2022
27
0.050
Why?
Proto-Oncogene Proteins c-bcl-2
1
2002
68
0.050
Why?
DNA
1
2004
365
0.050
Why?
Membrane Glycoproteins
1
2003
143
0.050
Why?
Tumor Necrosis Factor-alpha
1
2003
243
0.050
Why?
Mice, Nude
2
2017
313
0.050
Why?
Epithelial-Mesenchymal Transition
1
2022
110
0.050
Why?
Platelet-Derived Growth Factor
1
2021
25
0.050
Why?
Genetic Vectors
2
2017
107
0.050
Why?
Xenograft Model Antitumor Assays
2
2017
251
0.050
Why?
Tumor Escape
1
2021
8
0.050
Why?
Liquid Biopsy
1
2021
8
0.050
Why?
Neoplastic Cells, Circulating
1
2021
24
0.050
Why?
Cancer Vaccines
1
2021
32
0.050
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2021
57
0.050
Why?
Transforming Growth Factor beta
1
2021
77
0.040
Why?
Hypoglycemic Agents
1
2021
106
0.040
Why?
Pharmaceutical Vehicles
1
2020
7
0.040
Why?
Time Factors
1
2004
1570
0.040
Why?
Folate Receptors, GPI-Anchored
1
2020
6
0.040
Why?
Mice
4
2016
4472
0.040
Why?
Prostatic Neoplasms
1
2003
270
0.040
Why?
Interleukin-6
1
2021
189
0.040
Why?
Workflow
1
2020
25
0.040
Why?
Microscopy, Electron, Transmission
1
2020
80
0.040
Why?
Biomedical Research
1
2020
93
0.040
Why?
Lung
2
2016
363
0.040
Why?
HeLa Cells
1
2019
206
0.040
Why?
A549 Cells
1
2017
16
0.040
Why?
G1 Phase
1
2017
15
0.040
Why?
Static Electricity
1
2017
34
0.040
Why?
Cell Cycle Checkpoints
1
2017
30
0.040
Why?
Tissue Distribution
1
2017
132
0.030
Why?
Muscle Cells
1
2016
15
0.030
Why?
RNA Interference
1
2017
135
0.030
Why?
Gene Knockdown Techniques
1
2017
131
0.030
Why?
Ligands
1
2017
168
0.030
Why?
Transferrin
1
2015
8
0.030
Why?
Benzylamines
1
2015
19
0.030
Why?
Coronary Vessels
1
2016
151
0.030
Why?
Immunoprecipitation
1
2015
68
0.030
Why?
Hydrogen-Ion Concentration
1
2015
262
0.030
Why?
Cholesterol
1
2016
182
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2015
129
0.030
Why?
TOR Serine-Threonine Kinases
1
2015
76
0.030
Why?
Enzyme-Linked Immunosorbent Assay
1
2015
253
0.030
Why?
Fluorescamine
1
2014
2
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2015
325
0.030
Why?
Inhibitory Concentration 50
1
2014
34
0.030
Why?
Polyesters
1
2014
33
0.030
Why?
Chemistry, Pharmaceutical
1
2014
26
0.030
Why?
Particle Size
1
2014
96
0.030
Why?
Plasmids
1
2014
122
0.030
Why?
Radiopharmaceuticals
1
2014
69
0.030
Why?
Contrast Media
1
2014
94
0.030
Why?
RNA, Messenger
1
2015
648
0.030
Why?
Cesium Radioisotopes
1
2012
4
0.030
Why?
Tumor Stem Cell Assay
1
2012
5
0.030
Why?
Predictive Value of Tests
1
2014
472
0.030
Why?
Curcumin
2
2003
67
0.020
Why?
Anti-Bacterial Agents
1
2015
497
0.020
Why?
Electrophoresis, Gel, Pulsed-Field
1
2008
6
0.020
Why?
Stem Cell Transplantation
1
2007
17
0.020
Why?
Luciferases
1
2007
49
0.020
Why?
Radiotherapy
1
2008
39
0.020
Why?
Genetic Engineering
1
2007
23
0.020
Why?
Immunoblotting
1
2008
123
0.020
Why?
Mice, Inbred BALB C
1
2007
264
0.020
Why?
Inhibitor of Apoptosis Proteins
1
2006
13
0.020
Why?
Purines
1
2006
14
0.020
Why?
Oligonucleotides, Antisense
1
2006
22
0.020
Why?
CDC2 Protein Kinase
1
2006
15
0.020
Why?
Flavonoids
1
2006
30
0.020
Why?
Granzymes
1
2006
2
0.020
Why?
Transplantation, Heterologous
1
2006
60
0.020
Why?
Drug Evaluation, Preclinical
1
2006
57
0.020
Why?
Cell Division
1
2006
153
0.020
Why?
Adjuvants, Immunologic
1
2006
63
0.020
Why?
Neoplasm Metastasis
1
2006
150
0.020
Why?
Recombinant Fusion Proteins
1
2006
229
0.010
Why?
Skin Neoplasms
1
2006
118
0.010
Why?
Umbilical Veins
1
2004
25
0.010
Why?
Fibroblast Growth Factors
1
2004
22
0.010
Why?
MAP Kinase Kinase Kinase 2
1
2003
1
0.010
Why?
Anisomycin
1
2003
3
0.010
Why?
Activating Transcription Factor 2
1
2003
4
0.010
Why?
Cycloheximide
1
2003
10
0.010
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2003
4
0.010
Why?
MAP Kinase Kinase Kinases
1
2003
5
0.010
Why?
Protein Synthesis Inhibitors
1
2003
13
0.010
Why?
Recombinant Proteins
1
2004
408
0.010
Why?
JNK Mitogen-Activated Protein Kinases
1
2003
33
0.010
Why?
Glioma
1
2004
117
0.010
Why?
Apoptosis Regulatory Proteins
1
2003
33
0.010
Why?
Cyclic AMP Response Element-Binding Protein
1
2003
25
0.010
Why?
Vascular Endothelial Growth Factor A
1
2004
177
0.010
Why?
Nocodazole
1
2002
11
0.010
Why?
Proto-Oncogene Proteins c-jun
1
2002
12
0.010
Why?
Imidazoles
1
2003
60
0.010
Why?
G2 Phase
1
2002
15
0.010
Why?
fas Receptor
1
2002
19
0.010
Why?
bcl-2-Associated X Protein
1
2002
36
0.010
Why?
Gene Expression Regulation, Enzymologic
1
2003
93
0.010
Why?
Mitosis
1
2002
109
0.010
Why?
Proto-Oncogene Proteins
1
2002
139
0.010
Why?
Up-Regulation
1
2002
241
0.010
Why?
Peptide Fragments
1
2003
200
0.010
Why?
Endothelial Cells
1
2004
331
0.010
Why?
Disease Models, Animal
1
2006
1405
0.010
Why?
Mutation
1
2004
818
0.010
Why?
Transcription Factors
1
2003
512
0.010
Why?
Male
2
2004
13019
0.010
Why?
Munshi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (267)
Explore
_
Co-Authors (18)
Explore
_
Similar People (59)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_